These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4370 related articles for article (PubMed ID: 6239688)

  • 1. The isolation of immunogenic molecular entities from immunogenic and nonimmunogenic tumor homogenates by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
    Sharon R; Naor D
    Cancer Immunol Immunother; 1984; 18(3):203-8. PubMed ID: 6239688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. III. Stimulation of syngeneic antitumor responses by subcellular fractions and molecular species of Moloney virus-induced tumors in CBA and A mice.
    Ahituv A; Naor D; Sharon R; Tarcic N; Klein BY
    Cancer Immunol Immunother; 1982; 14(1):16-26. PubMed ID: 6186365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated soluble fractions from the murine B16 melanoma induce primary in vitro syngeneic antitumor responses.
    Klein BY; Frenkel S; Naor D
    Cancer Immunol Immunother; 1984; 18(3):195-202. PubMed ID: 6239687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antitumor reactive cells or suppressor cells by different molecular species isolated from the same nonimmunogenic tumor.
    Klein BY; Sharon R; Tarcic N; Naor D
    Immunobiology; 1982 Oct; 163(1):7-21. PubMed ID: 6217150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VIII. Characterization of suppressor cells.
    Deutsch O; Devens B; Naor D
    Isr J Med Sci; 1980 Jul; 16(7):538-44. PubMed ID: 6447123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to weakly immunogenic virally induced tumors. IX. Mice injected with the in vitro variant of YAC tumor (YAC-1) resist lethal doses of the tumorigenic YAC cells.
    Devens B; Deutsch O; Avraham Y; Naor D
    Immunobiology; 1981; 159(4-5):432-43. PubMed ID: 7287048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to weakly immunogenic virally induced tumors. II. Suppressive effects of the in vivo carried tumor YAC.
    Devens B; Galili N; Deutsch O; Naor D; Klein E
    Eur J Immunol; 1978 Aug; 8(8):573-8. PubMed ID: 699954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to weakly immunogenic virally induced tumors. III. Genetically unrestricted cytolysis of allogeneic tumor target cells.
    Devens B; Naor D
    J Immunol; 1979 Apr; 122(4):1397-401. PubMed ID: 312839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to weakly immunogenic virally induced tumors. I. Overcoming low responsiveness by priming mice with a syngeneic in vitro tumor line or allogeneic cross-reactive tumor.
    Galili N; Devens B; Naor D; Becker S; Klein E
    Eur J Immunol; 1978 Jan; 8(1):17-22. PubMed ID: 639838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VII. Kinetic studies on various parameters of effects induced with suppressor cells.
    Deutsch O; Devens B; Naor D
    Isr J Med Sci; 1980 Jul; 16(7):530-7. PubMed ID: 6447122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of tumor cells modified by trinitrobenzene suflonic acid (TNBS).
    Kedar E; Unger E; Galili N; Klein G; Asjo B; Bonavida B; Naor D
    Prog Clin Biol Res; 1976; 9():109-21. PubMed ID: 1030796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity against Brugia malayi infective larvae in mice. II. Induction by a T cell-dependent antigen isolated by monoclonal antibody affinity chromatography and SDS-PAGE.
    Hammerberg B; Nogami S; Nakagaki K; Hayashi Y; Tanaka H
    J Immunol; 1989 Dec; 143(12):4201-7. PubMed ID: 2480388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: their role in direct rejection of the melanoma and in prevention of tumorigenesis in Winn assays.
    Calvelli TA; Freedman VH; Silverstein SC; Silagi S
    J Exp Med; 1982 Dec; 156(6):1723-38. PubMed ID: 6983560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
    Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
    Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic antitumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor.
    Kobrin BJ; Naor D; Klein BY
    J Immunol; 1981 May; 126(5):1874-82. PubMed ID: 6260859
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE
    Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
    Giovarelli M; Santoni A; Forni G
    J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. I. Screening of immunogenic components by isopycnic ultracentrifugation and polyacrylamide electrophoresis of a tumor homogenate.
    Klein BY; Frenkel S; Ahituv A; Naor D
    J Immunol Methods; 1980; 38(3-4):325-41. PubMed ID: 6160183
    [No Abstract]   [Full Text] [Related]  

  • 20. Discussion paper: protective immunity in leukemic mice treated with specific "immunogenic" RNA.
    Friedman H
    Ann N Y Acad Sci; 1976; 277(00):708-15. PubMed ID: 1069568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 219.